Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International



Home > Directory > Life Sciences > Oasmia Pharmaceutical AB.

Oasmia Pharmaceutical AB.

Oasmia Pharmaceutical AB develops second and third generation cancer drugs based on nanotechnology for human and veterinary use. The broad portfolio is focused on oncology and contains several promising products in clinical and pre-clinical phase. Oasmia cooperates with leading universities and other biotech companies to discover and optimize substances with a favourable safety profile and better efficacy. The company was founded in 1998 and is based in Uppsala, Sweden.

Website

Vallongatan 1
Uppsala SE-752 28 Sweden
+46 18 50 54 40

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project